Organigram Makes Key Hire to Advance Oils and Extracts Division

Visit the OrganiGram Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Organigram large logo

MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 13, 2017) – Licensed medical marijuana producer Organigram Holdings Inc. (“Organigram” or the “Company”) (TSXV: OGI) (OTCQ: OGRMF) is pleased to announce the addition of Michel Robichaud to its Senior Management Team. Mr. Robichaud will join Organigram as of January 30th, 2017, as Director of Edibles & Extraction, a key role in the company’s leadership vision within the Canadian cannabis landscape.

Mr. Robichaud brings a wide breadth of experience to the company as a formally trained chemist with over 20 years of senior business leadership experience. Most recently, he had led projects of an international scope with JD Irving, and has managed laboratory operations with International mining company Rio Tinto. As a black belt certified professional, Mr. Robichaud has led development projects fully leveraging the benefits of lean, six sigma & Theory of Constraint systems.

“This positon is a critical strategic pillar as it leads a team working closely with TGS Colorado, our partner in extract development,” says Denis Arsenault, CEO of Organigram. “Michel’s experience and professionalism will help us ensure competitive advantage, allowing us to leverage the experience of TGS and get to market faster.”

Our recent land purchase and focus on this opportunity communicates a clear strategy on extract and edible manufacturing as it relates to the legalisation of recreational marijuana. We’re ecstatic about Mr. Robichaud joining the team and feel it’s one more step in ensuring Organigram does the groundwork now to ensure full preparedness for the recreational marketplace.

denis arsenaultDenis Arsenault, CEO of Organigram

Following the recently announced expansion plans, Mr. Robichaud will lead the design, build and implementation stages of a new state-of-the-art facility for allowable edible products under what is currently being established as Canada’s recreational framework for Cannabis.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

Original press release:

For fact-based information on Organigram, view the company’s sponsored Investor Dashboard.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter